463 related articles for article (PubMed ID: 19519445)
1. The therapeutic impact of manipulating microbiota in inflammatory bowel disease.
Kanauchi O; Mitsuyama K; Andoh A
Curr Pharm Des; 2009; 15(18):2074-86. PubMed ID: 19519445
[TBL] [Abstract][Full Text] [Related]
2. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
Wasilewski A; Zielińska M; Storr M; Fichna J
Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
Hedin C; Whelan K; Lindsay JO
Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
[TBL] [Abstract][Full Text] [Related]
4. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
Verbeke KA; Boesmans L; Boets E
Proc Nutr Soc; 2014 Nov; 73(4):490-7. PubMed ID: 24969143
[TBL] [Abstract][Full Text] [Related]
5. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives.
Roy S; Dhaneshwar S
World J Gastroenterol; 2023 Apr; 29(14):2078-2100. PubMed ID: 37122604
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
Geier MS; Butler RN; Howarth GS
Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
[TBL] [Abstract][Full Text] [Related]
7. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
Serban DE
Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
[TBL] [Abstract][Full Text] [Related]
8. Probiotics and their derivatives as treatments for inflammatory bowel disease.
Prisciandaro L; Geier M; Butler R; Cummins A; Howarth G
Inflamm Bowel Dis; 2009 Dec; 15(12):1906-14. PubMed ID: 19373788
[TBL] [Abstract][Full Text] [Related]
9. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
Heilpern D; Szilagyi A
Rev Recent Clin Trials; 2008 Sep; 3(3):167-84. PubMed ID: 18782075
[TBL] [Abstract][Full Text] [Related]
10. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility.
Scaldaferri F; Gerardi V; Lopetuso LR; Del Zompo F; Mangiola F; Boškoski I; Bruno G; Petito V; Laterza L; Cammarota G; Gaetani E; Sgambato A; Gasbarrini A
Biomed Res Int; 2013; 2013():435268. PubMed ID: 23991417
[TBL] [Abstract][Full Text] [Related]
11. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
Mitsuyama K; Sata M
Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
13. Prebiotics, synbiotics and inflammatory bowel disease.
Steed H; Macfarlane GT; Macfarlane S
Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
[TBL] [Abstract][Full Text] [Related]
14. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
Yu CG; Huang Q
J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
[TBL] [Abstract][Full Text] [Related]
15. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
Satokari R
Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
[TBL] [Abstract][Full Text] [Related]
16. The new prophylactic strategy for colon cancer in inflammatory bowel disease by modulating microbiota.
Kanauchi O; Mitsuyama K; Andoh A
Scand J Gastroenterol; 2013 Apr; 48(4):387-400. PubMed ID: 23249220
[TBL] [Abstract][Full Text] [Related]
17. Microbes, intestinal inflammation and probiotics.
Khan MW; Kale AA; Bere P; Vajjala S; Gounaris E; Pakanati KC
Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):81-94. PubMed ID: 22149584
[TBL] [Abstract][Full Text] [Related]
18. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
Seksik P; Dray X; Sokol H; Marteau P
Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
[TBL] [Abstract][Full Text] [Related]
19. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD.
Martyniak A; Medyńska-Przęczek A; Wędrychowicz A; Skoczeń S; Tomasik PJ
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944546
[TBL] [Abstract][Full Text] [Related]
20. Probiotics and prebiotics in chronic inflammatory bowel diseases.
Ewaschuk JB; Dieleman LA
World J Gastroenterol; 2006 Oct; 12(37):5941-50. PubMed ID: 17009391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
